Two case reports of skin vasculitis following the COVID-19 immunization

The coronavirus 2019 (COVID-19) disease is now responsible for one of the most challenging and concerning pandemics. Since December 2020, the world has had access to COVID-19 prophylaxis; thus, we encounter adverse events from vaccination more often due to the vast vaccination range. We present two...

Descripción completa

Detalles Bibliográficos
Autores principales: Chomičienė, Anželika, Černiauskas, Kęstutis, Linauskienė, Kotryna, Meškauskas, Raimundas, Malinauskienė, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743192/
https://www.ncbi.nlm.nih.gov/pubmed/36561846
http://dx.doi.org/10.1515/med-2022-0608
_version_ 1784848680338063360
author Chomičienė, Anželika
Černiauskas, Kęstutis
Linauskienė, Kotryna
Meškauskas, Raimundas
Malinauskienė, Laura
author_facet Chomičienė, Anželika
Černiauskas, Kęstutis
Linauskienė, Kotryna
Meškauskas, Raimundas
Malinauskienė, Laura
author_sort Chomičienė, Anželika
collection PubMed
description The coronavirus 2019 (COVID-19) disease is now responsible for one of the most challenging and concerning pandemics. Since December 2020, the world has had access to COVID-19 prophylaxis; thus, we encounter adverse events from vaccination more often due to the vast vaccination range. We present two case reports of difficult-to-treat skin vasculitis due to COVID-19 vaccination that were successfully treated in a tertiary-level university hospital. When encountering systemic treatment, resistant skin vasculitis plasmapheresis could be a choice of treatment.
format Online
Article
Text
id pubmed-9743192
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-97431922022-12-21 Two case reports of skin vasculitis following the COVID-19 immunization Chomičienė, Anželika Černiauskas, Kęstutis Linauskienė, Kotryna Meškauskas, Raimundas Malinauskienė, Laura Open Med (Wars) Case Report The coronavirus 2019 (COVID-19) disease is now responsible for one of the most challenging and concerning pandemics. Since December 2020, the world has had access to COVID-19 prophylaxis; thus, we encounter adverse events from vaccination more often due to the vast vaccination range. We present two case reports of difficult-to-treat skin vasculitis due to COVID-19 vaccination that were successfully treated in a tertiary-level university hospital. When encountering systemic treatment, resistant skin vasculitis plasmapheresis could be a choice of treatment. De Gruyter 2022-12-09 /pmc/articles/PMC9743192/ /pubmed/36561846 http://dx.doi.org/10.1515/med-2022-0608 Text en © 2022 the author(s), published by De Gruyter https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Case Report
Chomičienė, Anželika
Černiauskas, Kęstutis
Linauskienė, Kotryna
Meškauskas, Raimundas
Malinauskienė, Laura
Two case reports of skin vasculitis following the COVID-19 immunization
title Two case reports of skin vasculitis following the COVID-19 immunization
title_full Two case reports of skin vasculitis following the COVID-19 immunization
title_fullStr Two case reports of skin vasculitis following the COVID-19 immunization
title_full_unstemmed Two case reports of skin vasculitis following the COVID-19 immunization
title_short Two case reports of skin vasculitis following the COVID-19 immunization
title_sort two case reports of skin vasculitis following the covid-19 immunization
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743192/
https://www.ncbi.nlm.nih.gov/pubmed/36561846
http://dx.doi.org/10.1515/med-2022-0608
work_keys_str_mv AT chomicieneanzelika twocasereportsofskinvasculitisfollowingthecovid19immunization
AT cerniauskaskestutis twocasereportsofskinvasculitisfollowingthecovid19immunization
AT linauskienekotryna twocasereportsofskinvasculitisfollowingthecovid19immunization
AT meskauskasraimundas twocasereportsofskinvasculitisfollowingthecovid19immunization
AT malinauskienelaura twocasereportsofskinvasculitisfollowingthecovid19immunization

Ejemplares similares